We are live on ! Find out more

37 hedge funds and large institutions have $15.2M invested in Imunon in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 3

581% more capital invested

Capital invested by funds: $2.24M → $15.2M (+$13M)

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

95% more funds holding

Funds holding: 1937 (+18)

76% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $1.08M

0.02% more ownership

Funds ownership: 0.04%0.07% (+0.02%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
37
Holders Change
+18
Holders Change %
+94.74%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
9
Reduced
2
Closed
3
Calls
$1.9M
Puts
$1.08M
Net Calls
+$820K
Net Calls Change
+$738K

IMNN Hedge Fund Activity: Q2 2020 in Review

37 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2020, worth a combined $15.2M — up 581% from $2.24M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IMNN positions and 3 closed out — a net gain of 18 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.39M. The largest seller was CVI Holdings, exiting entirely with an estimated $1.03M sold.

  • 37 institutional investors held Imunon (IMNN) as of Q2 2020, up from 19 in Q1 2020.
  • Funds reported $15.2M of Imunon stock for Q2 2020, up 581% quarter-over-quarter.
  • 21 funds opened new Imunon positions in Q2 2020 and 3 closed out, a net change of +18 holders.
  • The largest Imunon buyer in Q2 2020 was Vanguard Group, an estimated $1.39M added.
  • The largest Imunon seller in Q2 2020 was CVI Holdings, an estimated $1.03M sold.

Based on aggregated 13F filings for Q2 2020.